Cargando…

Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report

One of the biggest challenges in treating depression is the heterogeneous and qualitative nature of its clinical presentations. This highlights the need to find quantitative molecular markers to tailor existing treatment strategies to the individual’s biological system. In this study, high-resolutio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caspani, Giorgia, Turecki, Gustavo, Lam, Raymond W., Milev, Roumen V., Frey, Benicio N., MacQueen, Glenda M., Müller, Daniel J., Rotzinger, Susan, Kennedy, Sidney H., Foster, Jane A., Swann, Jonathan R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298446/ https://www.ncbi.nlm.nih.gov/pubmed/34294869 http://dx.doi.org/10.1038/s42003-021-02421-6

Ejemplares similares

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response
por: Fiori, Laura M., et al.
Publicado: (2021)

Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report
por: Yrondi, Antoine, et al.
Publicado: (2019)

Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication
por: Schwartzmann, Benjamin, et al.
Publicado: (2023)

Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants
por: Ju, Chelsey, et al.
Publicado: (2019)

Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report
por: Harris, Jacqueline K., et al.
Publicado: (2022)

An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report
por: Suh, Jee Su, et al.
Publicado: (2020)

The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report
por: Harkness, Kate L., et al.
Publicado: (2023)

Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report
por: Yrondi, Antoine, et al.
Publicado: (2021)

Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1
por: Nunez, John-Jose, et al.
Publicado: (2021)

Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
por: Marshe, Victoria S., et al.
Publicado: (2021)

Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants
por: Hassel, Stefanie, et al.
Publicado: (2019)

Exploring brain connectivity changes in major depressive disorder using functional‐structural data fusion: A CAN‐BIND‐1 study
por: Ayyash, Sondos, et al.
Publicado: (2021)

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
por: Lopez, Juan Pablo, et al.
Publicado: (2017)

Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report
por: Sajjadian, Mehri, et al.
Publicado: (2023)

Gut microbial metabolites in depression: understanding the biochemical mechanisms
por: Caspani, Giorgia, et al.
Publicado: (2019)

Pro-inflammatory markers predict response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
por: Husain, M. I., et al.
Publicado: (2023)

Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort
por: Lam, Raymond W., et al.
Publicado: (2016)

Multisite Comparison of MRI Defacing Software Across Multiple Cohorts
por: Theyers, Athena E., et al.
Publicado: (2021)

Magnetic Resonance Imaging Sequence Identification Using a Metadata Learning Approach
por: Liang, Shuai, et al.
Publicado: (2021)

Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report
por: Ballester, Pedro L., et al.
Publicado: (2021)

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants
por: Lin, Rixing, et al.
Publicado: (2023)

“One Degree of Separation”: A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19
por: Ceniti, Amanda K., et al.
Publicado: (2022)

Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
por: Schwartzmann, Benjamin, et al.
Publicado: (2023)

Microbe-Immune Crosstalk: Evidence That T Cells Influence the Development of the Brain Metabolome
por: Caspani, Giorgia, et al.
Publicado: (2022)

Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
por: Espinola, Caroline W., et al.
Publicado: (2022)

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
por: Islam, Farhana, et al.
Publicado: (2022)

Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response
por: Fiori, Laura M, et al.
Publicado: (2017)

A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
por: Slyepchenko, Anastasiya, et al.
Publicado: (2023)

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
por: Oluboka, Oloruntoba J, et al.
Publicado: (2017)

A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol
por: Phillips, Jennifer L., et al.
Publicado: (2020)

Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression
por: Zhdanov, Andrey, et al.
Publicado: (2020)

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
por: Yatham, Lakshmi N, et al.
Publicado: (2018)

A detailed manual segmentation procedure for the hypothalamus for 3T T1-weighted MRI
por: Ali, Mohammad, et al.
Publicado: (2022)

A postmenopausal woman presenting with Ekbom syndrome associated with recurrent depressive disorder: a case report
por: Mahler, Courtney, et al.
Publicado: (2008)

Psychological Factors in Asthma
por: Van Lieshout, Ryan J, et al.
Publicado: (2008)

The Role of Adipokines in Understanding the Associations between Obesity and Depression
por: Taylor, Valerie H., et al.
Publicado: (2010)

S80. NEUROCOGNITIVE FUNCTIONING IN YOUTH AT RISK OF SERIOUS MENTAL ILLNESS
por: Romanowska, Sylvia, et al.
Publicado: (2018)

GPR56/ADGRG1 is associated with response to antidepressant treatment
por: Belzeaux, Raoul, et al.
Publicado: (2020)

Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression
por: Farzan, Faranak, et al.
Publicado: (2017)

Youth at-risk for serious mental illness: methods of the PROCAN study
por: Addington, Jean, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ie3ipb1srht730go7b8clo3rc7